Recent advances and emerging therapies in the non-surgical management of ulcerative colitis [version 1; referees: 3 approved]
The so-called “biologicals” (monoclonal antibodies to various inflammatory targets like tumor necrosis factor or integrins) have revolutionized the treatment of inflammatory bowel diseases. In ulcerative colitis, they have an established role in inducing remission in steroid-refractory disease and,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-08-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-1207/v1 |